Literature DB >> 19804179

Is Helicobacter pylori a cause of atrial fibrillation?

Peter Andrew1, Annibale Sandro Montenero.   

Abstract

Inflammation has been implicated in the pathogenesis of cardiovascular diseases. C-reactive protein, a sensitive marker of systemic inflammation, has recently been reported to be significantly higher in patients with atrial fibrillation (AF) compared with a control group with no history of atrial arrhythmia. Elevated C-reactive protein levels in patients with AF reflects an underlying inflammatory process. Histological anomalies in the atria of patients with AF have also been observed. These anomalies may have an inflammatory basis, although it is not known if any structural changes within the atria are a cause or a consequence of the arrhythmia. Ongoing chronic infection(s) has been suggested as a possible cause of the inflammatory process demonstrated in patients with AF. Helicobacter pylori, a Gram-negative bacterium more commonly known for infecting the gastric mucosa and causing peptic ulcers, is a noncardiac factor that has been controversially reported to be associated with cardiovascular diseases. This article gives a brief overview of AF and specifically explores the recent evidence that suggests that Helicobacter pylori infection causes AF.

Entities:  

Year:  2006        PMID: 19804179     DOI: 10.2217/14796678.2.4.429

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  3 in total

1.  Helicobacter pylori infection in Chinese patients with atrial fibrillation.

Authors:  De-Zhao Wang; Wei Chen; Song Yang; Jun Wang; Qun Li; Qiang Fu; Shi-Jing Li; Bu-Xing Chen
Journal:  Clin Interv Aging       Date:  2015-04-28       Impact factor: 4.458

2.  The Risk of Atrial Fibrillation after Herpes Zoster.

Authors:  Young Soo Lee
Journal:  J Korean Med Sci       Date:  2018-05-21       Impact factor: 2.153

Review 3.  Association between atrial fibrillation and Helicobacter pylori.

Authors:  Cecilia Tetta; Amalia Ioanna Moula; Francesco Matteucci; Orlando Parise; Bart Maesen; Daniel Johnson; Mark La Meir; Sandro Gelsomino
Journal:  Clin Res Cardiol       Date:  2019-02-08       Impact factor: 5.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.